News

In a new development for prostate cancer treatment, the FDA has approved the use of Xtandi (enzalutamide) in combination with leuprolide for patients with high-risk prostate cancer. This approval introduces a promising new option for managing advanced stages of the disease. Promising Results in Clinical Trials The combination of Xtandi and leuprolide has been shown […]

In the realm of neonatal care, the management of a newborn’s umbilical cord has always been a topic of great importance. Recent advancements in medical research have brought forth new approaches that are transforming the way healthcare professionals handle this crucial aspect of newborn care. Traditionally, the umbilical cord was clamped and cut immediately after

The landscape of abdominal surgery is undergoing a significant transformation, thanks to the advent of innovative technologies. This article delves into some of the latest advancements that are set to redefine the future of abdominal surgical procedures. Robotic Surgery: A Game Changer Robotic surgery, a technology that has been around for over two decades, is

The world of medicine is witnessing a paradigm shift in the battle against antibiotic resistance. Recent breakthroughs have unveiled innovative strategies to combat this global health threat, offering a glimmer of hope in the face of rising superbugs. A team of scientists from Imperial College London has discovered a novel approach to impair antibiotic-resistant bacteria.

In a significant development on December 22, 2022, the U.S. Food and Drug Administration (FDA) approved a new antiretroviral medication, Sunlenca (lenacapavir), for adult patients living with human immunodeficiency virus type 1 (HIV-1). This approval marks an important moment in the evolution of HIV treatment, introducing a novel class of drugs known as capsid inhibitors